IOB Stock Overview
Develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Ion Beam Applications SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €13.56 |
| 52 Week High | €14.96 |
| 52 Week Low | €9.35 |
| Beta | 0.99 |
| 11 Month Change | -1.74% |
| 3 Month Change | 13.57% |
| 1 Year Change | 23.50% |
| 33 Year Change | -5.31% |
| 5 Year Change | -0.29% |
| Change since IPO | -25.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| IOB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 7.6% | 2.4% | 0.8% |
| 1Y | 23.5% | -5.0% | 9.1% |
Return vs Industry: IOB exceeded the German Medical Equipment industry which returned -5% over the past year.
Return vs Market: IOB exceeded the German Market which returned 9.1% over the past year.
Price Volatility
| IOB volatility | |
|---|---|
| IOB Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IOB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: IOB's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 1,943 | Olivier Legrain | www.iba-worldwide.com |
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.
Ion Beam Applications SA Fundamentals Summary
| IOB fundamental statistics | |
|---|---|
| Market cap | €391.03m |
| Earnings (TTM) | €7.85m |
| Revenue (TTM) | €465.75m |
49.8x
P/E Ratio0.8x
P/S RatioIs IOB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IOB income statement (TTM) | |
|---|---|
| Revenue | €465.75m |
| Cost of Revenue | €306.52m |
| Gross Profit | €159.24m |
| Other Expenses | €151.39m |
| Earnings | €7.85m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 20, 2025
| Earnings per share (EPS) | 0.27 |
| Gross Margin | 34.19% |
| Net Profit Margin | 1.69% |
| Debt/Equity Ratio | 35.9% |
How did IOB perform over the long term?
See historical performance and comparison